Arteriosclerosis and Thrombosis, Vol 14, 125-132, Copyright © 1994 by American Heart Association

ARTICLES

Polymorphonuclear leukocytes enhance release of growth factors by cultured endothelial cells

L Totani, A Piccoli, G Pellegrini, A Di Santo and R Lorenzet
Antonio Taticchi Unit for Atheroselerosis and Thrombosis Research, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.

Porcine aortic endothelial cells (PAECs) in culture constitutively secrete polypeptide (endothelium-derived) growth factors (EDGFs) into the surrounding medium. Incubation of PAECs with human peripheral blood polymorphonuclear leukocytes (PMNs) caused a significant increase in EDGF release as assessed by [3H]thymidine incorporation into BALB/c 3T3 mouse fibroblasts and cell proliferation assay. The effect was time dependent and correlated with the number of PMNs, reaching a maximum with a 1:1 PAEC to PMN ratio. Generation of mitogenic activity was prevented by cycloheximide, indicating a requirement for de novo protein synthesis. Antibody-mediated inhibition assays suggested that mitogenic activity was due to platelet-derived growth factor and basic fibroblast growth factor. When supernatant from N-formyl-methionyl- leucyl-phenylalanine-stimulated PMNs was substituted for PMNs during incubation with PAECs, powerful mitogenic activity was generated, indicating the involvement of soluble mediators. A role for free oxygen radicals was ruled out by experiments in which superoxide dismutase and catalase did not prevent the increase in mitogenic activity. By contrast, serine protease inhibitors such as soybean trypsin inhibitor, alpha 1-antitrypsin, and eglin C reduced the PMN-stimulating activity by 70%, 80%, and 100%, respectively. The possible involvement of cathepsin G and elastase was investigated. Cathepsin G and elastase, when substituted for PMNs, increased the release of EDGFs in a dose- dependent fashion, mimicking the effect of PMNs. These findings suggest a new role for leukocyte-vessel wall interactions in the proliferative feature of atherosclerosis.

This article has been cited by other articles:

				S. PERVAIZ Resveratrol: from grapevines to mammalian biology FASEB J, November 1, 2003; 17(14): 1975 - 1985. [Full Text] [PDF]

				A. M. Miller, A. R. McPhaden, R. M. Wadsworth, and C. L. Wainwright Inhibition by leukocyte depletion of neointima formation after balloon angioplasty in a rabbit model of restenosis Cardiovasc Res, March 1, 2001; 49(4): 838 - 850. [Abstract] [Full Text] [PDF]

				U. Bank and S. Ansorge More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control J. Leukoc. Biol., February 1, 2001; 69(2): 197 - 206. [Abstract] [Full Text]

				L. Totani, A. Cumashi, A. Piccoli, and R. Lorenzet Polymorphonuclear Leukocytes Induce PDGF Release From IL-1ߖTreated Endothelial Cells : Role of Adhesion Molecules and Serine Proteases Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1534 - 1540. [Abstract] [Full Text] [PDF]

				P. Schratzberger, S. Dunzendorfer, N. Reinisch, C. M Kahler, M. Herold, and C. J Wiedermann Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils Cardiovasc Res, May 1, 1998; 38(2): 516 - 521. [Abstract] [Full Text] [PDF]

				A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin Biological Roles of Fibroblast Growth Factor-2 Endocr. Rev., February 1, 1997; 18(1): 26 - 45. [Abstract] [Full Text]

				S. Oho, S. J. Daley, E. W.Y. Koo, T. Childs, A. I. Gotlieb, and M. Rabinovitch Increased Elastin-Degrading Activity and Neointimal Formation in Porcine Aortic Organ Culture : Reduction of Both Features With a Serine Proteinase Inhibitor Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2200 - 2206. [Abstract] [Full Text]

				L. Iacoviello, V. Kolpakov, L. Salvatore, C. Amore, G. Pintucci, G. de Gaetano, and M. B. Donati Human Endothelial Cell Damage by Neutrophil-Derived Cathepsin G : Role of Cytoskeleton Rearrangement and Matrix-Bound Plasminogen Activator Inhibitor-1 Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 2037 - 2046. [Abstract] [Full Text]